By Andrew Lines, MAI, Principal Valuations within the growing cannabis industry don’t always seem to be consistent with operator or investor expectations; this can be due […]
The Rohrabacher-Blumenauer Amendment works to protect medical cannabis programs in 29 states and the District of Columbia. The states most affected by a non-renewal of this […]
By J.J. McCoy, Senior Managing Editor for New Frontier Data Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) […]
Attorney General Jeff Sessions’ Jan. 4 announcement rescinding the Cole Memo sparked a steep but short-lived selloff of U.S. cannabis stocks. By January 11th, stocks had […]
By J.J. McCoy, Senior Managing Editor for New Frontier Data In a three-paragraph memo released on Thursday, U.S. Attorney General Jeff Sessions rescinded several Obama-era directives […]
The top 5 most clicked-on CannaBit topics of 2017 included projections for individual state markets, and how White House politics could affect the cannabis industry. By […]